Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52


Cardiac and renal complications of carfilzomib in patients with multiple myeloma.

Dimopoulos MA, Roussou M, Gavriatopoulou M, Psimenou E, Ziogas D, Eleutherakis-Papaiakovou E, Fotiou D, Migkou M, Kanellias N, Panagiotidis I, Ntalianis A, Papadopoulou E, Stamatelopoulos K, Manios E, Pamboukas C, Kontogiannis S, Terpos E, Kastritis E.

Blood Adv. 2017 Feb 27;1(7):449-454. doi: 10.1182/bloodadvances.2016003269. eCollection 2017 Feb 28.


Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib.

Kastritis E, Gavriatopoulou M, Roussou M, Fotiou D, Ziogas DC, Migkou M, Eleutherakis-Papaiakovou E, Panagiotidis I, Kanellias N, Psimenou E, Papadopoulou E, Pamboucas C, Manios E, Gakiopoulou H, Ntalianis A, Tasidou A, Giannouli S, Terpos E, Dimopoulos MA.

Blood Cancer J. 2017 Jun 16;7(6):e570. doi: 10.1038/bcj.2017.47.


Comparison of two biventricular infarct patterns with respect to the infarct burden required to induce cardiogenic shock: An experimental study.

Koudoumas D, Terrovitis J, Glentis P, Ntalianis A, Tsolakis E, Zannas AS, Tseliou E, Papalois A, Drakos S, Nanas JN.

Hellenic J Cardiol. 2017 Jul - Aug;58(4):306-309. doi: 10.1016/j.hjc.2016.11.035. Epub 2016 Dec 5. No abstract available.


The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion.

Nieminen MS, Buerke M, Cohen-Solál A, Costa S, Édes I, Erlikh A, Franco F, Gibson C, Gorjup V, Guarracino F, Gustafsson F, Harjola VP, Husebye T, Karason K, Katsytadze I, Kaul S, Kivikko M, Marenzi G, Masip J, Matskeplishvili S, Mebazaa A, Møller JE, Nessler J, Nessler B, Ntalianis A, Oliva F, Pichler-Cetin E, Põder P, Recio-Mayoral A, Rex S, Rokyta R, Strasser RH, Zima E, Pollesello P.

Int J Cardiol. 2016 Sep 1;218:150-157. doi: 10.1016/j.ijcard.2016.05.009. Epub 2016 May 14. Review.


Prolonged intra-aortic balloon pump support in biventricular heart failure induces right ventricular reverse remodeling.

Ntalianis A, Kapelios CJ, Kanakakis J, Repasos E, Pantsios C, Nana E, Kontogiannis C, Malliaras K, Tsamatsoulis M, Kaldara E, Charitos C, Nanas JN.

Int J Cardiol. 2015 Aug 1;192:3-8. doi: 10.1016/j.ijcard.2015.05.014. Epub 2015 May 8.


High furosemide dose has detrimental effects on survival of patients with stable heart failure.

Kapelios CJ, Kaldara E, Ntalianis A, Sousonis V, Repasos E, Sfakianaki T, Vakrou S, Pantsios C, Nanas JN, Terrovitis JV.

Hellenic J Cardiol. 2015 Mar-Apr;56(2):154-9.


Dabigatran etexilate as second-line therapy in patients with a left ventricular assist device.

Terrovitis JV, Ntalianis A, Kapelios CJ, Vakrou S, Diakos N, Katsaros L, Tsamatsoulis M, Kaldara E, Charitos C, Nanas JN.

Hellenic J Cardiol. 2015 Jan-Feb;56(1):20-5.


Intermittent renal replacement therapy for end stage drug refractory heart failure.

Repasos E, Kaldara E, Ntalianis A, Pantsios C, Kapelios C, Nana E, Grapsa E, Malliaras K, Nanas JN.

Int J Cardiol. 2015 Mar 15;183:24-6. doi: 10.1016/j.ijcard.2015.01.039. Epub 2015 Jan 27. No abstract available.


Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies.

Kastritis E, Roussou M, Gavriatopoulou M, Migkou M, Kalapanida D, Pamboucas C, Kaldara E, Ntalianis A, Psimenou E, Toumanidis ST, Tasidou A, Terpos E, Dimopoulos MA.

Am J Hematol. 2015 Apr;90(4):E60-5. doi: 10.1002/ajh.23936. Epub 2015 Mar 9.


Red blood cell distribution width is a significant prognostic marker in advanced heart failure, independent of hemoglobin levels.

Tseliou E, Terrovitis JV, Kaldara EE, Ntalianis AS, Repasos E, Katsaros L, Margari ZJ, Matsouka C, Toumanidis S, Nanas SN, Nanas JN.

Hellenic J Cardiol. 2014 Nov-Dec;55(6):457-61.


Effective radiation doses associated with non-invasive versus invasive assessment of coronary anatomy and physiology.

Toth GG, Ntalianis A, Ntarladimas Y, de Booij M, De Winter O, Barbato E, Pilet B, Van Mieghem C, Wijns W, De Bruyne B.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1173-81. doi: 10.1002/ccd.25729. Epub 2014 Nov 22.


Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study.

Kapelios CJ, Kaldara E, Ntalianis A, Nana E, Pantsios C, Repasos E, Margari Z, Sousonis V, Malliaras K, Nanas JN.

Int J Cardiol. 2014 Dec 15;177(2):690-2. doi: 10.1016/j.ijcard.2014.09.156. Epub 2014 Oct 8. No abstract available.


Value of apical circumferential strain in the early post-myocardial infarction period for prediction of left ventricular remodeling.

Bonios MJ, Kaladaridou A, Tasoulis A, Papadopoulou E, Pamboukas C, Ntalianis A, Kanakakis J, Terrovitis JV, Toumanidis ST.

Hellenic J Cardiol. 2014 Jul-Aug;55(4):305-12.


Beneficial effects of combined exercise training on early recovery cardiopulmonary exercise testing indices in patients with chronic heart failure.

Georgantas A, Dimopoulos S, Tasoulis A, Karatzanos E, Pantsios C, Agapitou V, Ntalianis A, Roditis P, Terrovitis J, Nanas S.

J Cardiopulm Rehabil Prev. 2014 Nov-Dec;34(6):378-85. doi: 10.1097/HCR.0000000000000068.


Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease.

Muller O, Ntalianis A, Wijns W, Delrue L, Dierickx K, Auer R, Rodondi N, Mangiacapra F, Trana C, Hamilos M, Valentin E, De Bruyne B, Barbato E, Bartunek J.

J Cardiovasc Transl Res. 2013 Aug;6(4):536-44. doi: 10.1007/s12265-013-9468-x. Epub 2013 May 14.


Hormonal imbalance in relation to exercise intolerance and ventilatory inefficiency in chronic heart failure.

Agapitou V, Dimopoulos S, Kapelios C, Karatzanos E, Manetos C, Georgantas A, Ntalianis A, Terrovitis J, Karga H, Nanas S.

J Heart Lung Transplant. 2013 Apr;32(4):431-6. doi: 10.1016/j.healun.2012.12.011. Epub 2013 Feb 9.


Elevated left ventricular filling pressures can be estimated with accuracy by a new mathematical model.

Terrovitis JV, Kapelios CJ, Sainis G, Ntalianis A, Kaldara E, Sousonis V, Vakrou S, Michelinakis N, Anagnostou D, Margari Z, Nanas JN.

J Heart Lung Transplant. 2013 May;32(5):511-7. doi: 10.1016/j.healun.2013.01.986. Epub 2013 Feb 9.


von Willebrand factor inhibition improves endothelial function in patients with stable angina.

Muller O, Bartunek J, Hamilos M, Berza CT, Mangiacapra F, Ntalianis A, Vercruysse K, Duby C, Wijns W, De Bruyne B, Heyndrickx GR, Vanderheyden M, Holz JB, Barbato E.

J Cardiovasc Transl Res. 2013 Jun;6(3):364-70. doi: 10.1007/s12265-012-9422-3. Epub 2012 Dec 12.


Intravenous iron alone is equally effective with the combination of iron and erythropoietin for the treatment of iron-deficiency anemia in advanced heart failure.

Terrovitis JV, Kaldara E, Ntalianis A, Sventzouri S, Kapelios C, Barbarousi D, Matsouka C, Nanas JN.

J Am Coll Cardiol. 2012 Nov 20;60(21):2255-6. doi: 10.1016/j.jacc.2012.05.065. Epub 2012 Oct 24. No abstract available.


Stent for Life Initiative--the Greek experience.

Kanakakis J, Ntalianis A, Papaioannou G, Hourdaki S, Parharidis G.

EuroIntervention. 2012 Aug;8 Suppl P:P116-20. doi: 10.4244/EIJV8SPA20. Review.


Supplemental Content

Loading ...
Support Center